Recombinant UPF0267 protein VPA1414 (VPA1414)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a reference.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
VPA1414; UPF0267 protein VPA1414
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-107
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633)
Target Names
VPA1414
Target Protein Sequence
MSSHPTKITF FEFLTPLITS GQKTITIRDE SESHYVPNTE VEVFTLETDR KVCDIKILSV EPLNFDEINE FHAEQEAIEL PKLKQLIREI YPNIDKLFVI EYELIKK
Uniprot No.

Target Background

Function
Catalyzes the hydrolysis of N(4)-acetylcytidine (ac4C).
Database Links

KEGG: vpa:VPA1414

STRING: 223926.VPA1414

Protein Families
UPF0267 family

Q&A

What is UPF0267 protein VPA1414 and what expression systems are optimal for its production?

UPF0267 protein VPA1414 is a recombinant protein that can be expressed in multiple host systems. According to research data, E. coli and yeast expression systems provide the best yields and shorter turnaround times for this protein, making them particularly suitable for initial characterization studies and applications where post-translational modifications are not critical . The "UPF" designation indicates it belongs to an uncharacterized protein family whose complete functions have yet to be fully determined through structural and functional analyses.

When should researchers choose insect or mammalian cell expression systems over bacterial systems for VPA1414?

Researchers should opt for insect cells with baculovirus or mammalian cell expression systems when studying VPA1414 in contexts where posttranslational modifications are necessary for correct protein folding or maintenance of biological activity . While these systems typically yield less protein and require longer production times compared to prokaryotic systems, they provide the eukaryotic cellular machinery needed for complex modifications that may be essential for certain experimental applications, particularly those investigating the protein's native structural conformations or functional interactions.

What storage conditions are recommended for maintaining VPA1414 stability?

For optimal stability of recombinant proteins like VPA1414, long-term storage should be at -20°C or -80°C, with working aliquots maintained at 4°C for up to one week to minimize degradation . Repeated freeze-thaw cycles should be avoided as they can lead to protein denaturation and loss of activity. When preparing aliquots, researchers should consider buffer composition, including appropriate stabilizers such as glycerol or specific salt concentrations that maintain protein integrity during the freeze-thaw process.

What methodological approaches can optimize VPA1414 expression in E. coli systems?

To optimize E. coli expression of VPA1414, researchers should implement a systematic optimization strategy that includes:

Optimization ParameterMethodological ApproachExpected Impact
Strain selectionTest BL21(DE3), Rosetta, OrigamiB strainsAddresses codon bias and disulfide bond formation
Induction conditionsVary IPTG (0.1-1.0 mM), temperature (16-37°C), time (2-24h)Balances yield vs. solubility
Media compositionCompare LB, TB, auto-induction mediaAffects cell density and protein yield
Co-expression strategiesAdd chaperones (GroEL/ES, DnaK)Improves folding and solubility
Fusion tagsTest His, GST, MBP, SUMO tagsEnhances solubility and facilitates purification

The optimization process should begin with small-scale expression trials that systematically test these variables before scaling up to larger production volumes for final purification.

What chromatography techniques are most effective for purifying VPA1414 expressed in different systems?

The purification strategy for VPA1414 should be tailored to the expression system used and the presence of affinity tags. General recommendations include:

  • For E. coli and yeast expressions: A two-step approach beginning with affinity chromatography (IMAC for His-tagged constructs) followed by size exclusion chromatography (SEC) typically achieves >90% purity .

  • For insect and mammalian expressions: More complex purification schemes may be necessary, potentially incorporating ion exchange chromatography between the affinity and size exclusion steps to remove host cell proteins that may interact with the target protein through post-translational modifications.

  • For tag-free preparations: Consider using specialized proteases (TEV, PreScission) for tag removal followed by negative affinity chromatography and polishing with SEC.

How can researchers assess the quality and functional integrity of purified VPA1414?

Quality assessment of purified VPA1414 should include multiple analytical techniques:

Analytical MethodApplicationCritical Parameters
SDS-PAGEPurity assessment≥95% purity by densitometry
Western blotIdentity confirmationSpecific antibody reactivity
Mass spectrometryMolecular weight verificationWithin 0.1% of theoretical mass
Size exclusion chromatographyAggregation analysis≥90% monomeric species
Circular dichroismSecondary structure evaluationConsistent spectral characteristics
Dynamic light scatteringSolution homogeneityPolydispersity index <0.2
Functional assaysActivity confirmationActivity comparable to standards

These methods collectively provide a comprehensive profile of the protein's physical and functional characteristics, ensuring reliable experimental outcomes.

How can long-range protein sequencing techniques be applied to study VPA1414 structure?

Recent advancements in nanopore technology offer promising approaches for analyzing VPA1414's structural characteristics. Researchers have developed methods for long-range, single-molecule sequencing of intact protein strands using Oxford Nanopore Technologies' MinIon device . This methodology involves:

  • Transporting the protein substrate through a nanopore via electrophoretic force

  • Using a blocking domain affixed to the C-terminal to prevent complete translocation

  • Adding ClpX (an ATP-powered protein unfoldase) to pull the analyte back through the pore in a controlled fashion

This technique could provide valuable insights into VPA1414's structural features that traditional sequencing methods might miss, particularly for identifying long-range interactions and conformational states.

What statistical considerations are important when designing experiments to study VPA1414 function?

When designing panel data experiments to investigate VPA1414 function across multiple conditions or time points, researchers should:

  • Account for arbitrary error structures and non-constant serial correlation in experimental design to avoid incorrectly powered experiments

  • Implement "serial-correlation-robust" power calculations to achieve properly powered experiments that can detect statistically significant effects

  • Consider variance components when determining sample sizes and replicate numbers

  • Apply appropriate statistical models that account for the specific error structure of the experimental data

These statistical considerations are crucial for ensuring that experiments investigating VPA1414 function yield reliable and reproducible results.

How can researchers investigate potential protein-protein interactions involving VPA1414?

To investigate VPA1414's potential interaction partners, researchers should employ a multi-faceted approach:

Interaction Analysis MethodStrengthLimitation
Yeast two-hybrid screeningIdentifies direct binary interactionsMay yield false positives/negatives
Co-immunoprecipitationDetects interactions in native conditionsRequires specific antibodies
Proximity labeling (BioID, APEX)Identifies proximal proteins in live cellsMay label nearby non-interacting proteins
Surface plasmon resonanceProvides binding kineticsRequires purified proteins
Crosslinking mass spectrometryMaps interaction interfacesComplex data analysis
Fluorescence resonance energy transferMeasures interactions in live cellsRequires fluorescent protein fusions

A combination of these methods provides the most comprehensive analysis of VPA1414's interactome and potential functional roles in cellular processes.

How can VPA1414 be studied in the context of intracellular protein trafficking pathways?

To study VPA1414 in cellular trafficking contexts, researchers can adapt approaches used for other trafficking proteins such as VPS proteins:

  • Generate fluorescently tagged VPA1414 constructs to track localization and movement through cellular compartments using live-cell imaging

  • Perform co-localization studies with established markers of various cellular compartments (early/late endosomes, Golgi, lysosomes) to determine its subcellular distribution

  • Conduct pulse-chase experiments to track the protein's movement through trafficking pathways

  • Use temperature blocks or chemical inhibitors of specific trafficking steps to determine where VPA1414 functions in the pathway

Understanding VPA1414's role in trafficking may provide insights into its cellular function and potential involvement in disease processes.

What approaches can determine if VPA1414 undergoes post-translational modifications in different expression systems?

Given that VPA1414 can be expressed in systems capable of post-translational modifications , researchers should employ these analytical approaches:

  • Mass spectrometry analysis (LC-MS/MS) with enrichment strategies specific for phosphorylation, glycosylation, or other modifications

  • Western blotting with modification-specific antibodies (e.g., anti-phospho, anti-ubiquitin)

  • Mobility shift assays to detect changes in electrophoretic mobility due to modifications

  • Site-directed mutagenesis of predicted modification sites to assess functional consequences

  • Comparison of protein expressed in different systems (E. coli vs. mammalian cells) to identify modification-dependent properties

These approaches can reveal how post-translational modifications affect VPA1414's structure, localization, and function in different cellular contexts.

What strategies can address common challenges in VPA1414 solubility and stability?

When encountering solubility or stability issues with VPA1414, researchers should implement this systematic troubleshooting approach:

ChallengeStrategyImplementation
Poor solubilityOptimize buffer conditionsTest pH range (6.0-8.5), salt concentrations (100-500 mM), and additives (glycerol, arginine, detergents)
Precipitation during concentrationAdjust concentration methodReduce centrifugal force, use dialysis or diafiltration instead of centrifugal concentrators
Degradation during purificationEnhance protease protectionAdd protease inhibitor cocktail, reduce purification time, maintain samples at 4°C
Aggregation during storageOptimize storage conditionsAdd stabilizers (10% glycerol, 1 mM DTT), aliquot to avoid freeze-thaw cycles
Loss of activityPreserve functional elementsInclude cofactors or binding partners, optimize buffer for activity maintenance

These approaches should be implemented systematically with appropriate controls to identify the most effective conditions for maintaining VPA1414 integrity.

How can researchers address expression variability between batches of VPA1414?

To ensure batch-to-batch consistency in VPA1414 expression:

  • Standardize seed culture conditions (media, growth phase, passage number)

  • Use consistent induction parameters (OD600 at induction, inducer concentration, temperature)

  • Implement rigorous quality control metrics for each purification step

  • Maintain detailed records of expression conditions and yields

  • Pool multiple small-scale expressions rather than single large-scale batches when consistency is critical

Additionally, researchers should consider implementing a reference standard system where each new batch is compared to a well-characterized reference batch using multiple analytical techniques to ensure functional equivalence.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.